| Giselle Lara, CAA | |
|
110 Irving St Nw, Washington, DC 20010-3017 | |
| (855) 546-1686 | |
| Not Available |
| Full Name | Giselle Lara |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 7 Years |
| Location | 110 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205364833 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Washington Hospital Center | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
A multicenter research team led jointly by Washington University School of Medicine in St. Louis and the University of North Carolina at Chapel Hill has received a five-year, $9.5 million grant to further evaluate whether brain imaging can help detect very high risk of autism spectrum disorder in early infancy.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
The increasing prevalence of lifestyle-related health risks coupled with the lack of resources in preventative healthcare calls for novel and cost-efficient methods for supporting citizens in their independent health and well-being management. Behaviour modification is an efficient way of preventing chronic diseases and other lifestyle-related health problems, provided that the healthy behaviours are sustained over the long term.
The international All.Can cancer initiative has today published a major report urging health officials, governments and decision-makers to 'do the right thing by patients' when developing cancer care plans and policies by taking patient insights into account in all aspects of treatment and care.
Scientists from Queen Mary, University of London have discovered a new protein complex operating in fruit fly circadian clocks, which may also help to regulate our own biological clocks.
› Verified 5 days ago
| Entity Name | Washington Hospital Center Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407870124 PECOS PAC ID: 3577476266 Enrollment ID: O20040630000173 |
News Archive
A multicenter research team led jointly by Washington University School of Medicine in St. Louis and the University of North Carolina at Chapel Hill has received a five-year, $9.5 million grant to further evaluate whether brain imaging can help detect very high risk of autism spectrum disorder in early infancy.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
The increasing prevalence of lifestyle-related health risks coupled with the lack of resources in preventative healthcare calls for novel and cost-efficient methods for supporting citizens in their independent health and well-being management. Behaviour modification is an efficient way of preventing chronic diseases and other lifestyle-related health problems, provided that the healthy behaviours are sustained over the long term.
The international All.Can cancer initiative has today published a major report urging health officials, governments and decision-makers to 'do the right thing by patients' when developing cancer care plans and policies by taking patient insights into account in all aspects of treatment and care.
Scientists from Queen Mary, University of London have discovered a new protein complex operating in fruit fly circadian clocks, which may also help to regulate our own biological clocks.
› Verified 5 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171129001837 |
News Archive
A multicenter research team led jointly by Washington University School of Medicine in St. Louis and the University of North Carolina at Chapel Hill has received a five-year, $9.5 million grant to further evaluate whether brain imaging can help detect very high risk of autism spectrum disorder in early infancy.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
The increasing prevalence of lifestyle-related health risks coupled with the lack of resources in preventative healthcare calls for novel and cost-efficient methods for supporting citizens in their independent health and well-being management. Behaviour modification is an efficient way of preventing chronic diseases and other lifestyle-related health problems, provided that the healthy behaviours are sustained over the long term.
The international All.Can cancer initiative has today published a major report urging health officials, governments and decision-makers to 'do the right thing by patients' when developing cancer care plans and policies by taking patient insights into account in all aspects of treatment and care.
Scientists from Queen Mary, University of London have discovered a new protein complex operating in fruit fly circadian clocks, which may also help to regulate our own biological clocks.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Giselle Lara, CAA 1501 Crystal Dr Apt 323, Arlington, VA 22202-4103 Ph: (815) 566-6762 | Giselle Lara, CAA 110 Irving St Nw, Washington, DC 20010-3017 Ph: (855) 546-1686 |
News Archive
A multicenter research team led jointly by Washington University School of Medicine in St. Louis and the University of North Carolina at Chapel Hill has received a five-year, $9.5 million grant to further evaluate whether brain imaging can help detect very high risk of autism spectrum disorder in early infancy.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.
The increasing prevalence of lifestyle-related health risks coupled with the lack of resources in preventative healthcare calls for novel and cost-efficient methods for supporting citizens in their independent health and well-being management. Behaviour modification is an efficient way of preventing chronic diseases and other lifestyle-related health problems, provided that the healthy behaviours are sustained over the long term.
The international All.Can cancer initiative has today published a major report urging health officials, governments and decision-makers to 'do the right thing by patients' when developing cancer care plans and policies by taking patient insights into account in all aspects of treatment and care.
Scientists from Queen Mary, University of London have discovered a new protein complex operating in fruit fly circadian clocks, which may also help to regulate our own biological clocks.
› Verified 5 days ago
Alexandra Megan Fine, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Alexa Aramini, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-3303 | |
Shelby Fullen, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Domenic Derobertis, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-854-7000 | |
Timothy Olukanni, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-715-4000 | |
Kanchanish Kaur, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-9418 | |
Elizabeth Stephenson, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 |